Teofilo Vasconcelos
Teofilo Vasconcelos
BIAL
Email confirmado em bial.com - Página inicial
Título
Citado por
Citado por
Ano
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12 (23-24), 1068-1075, 2007
15642007
Amorphous solid dispersions: Rational selection of a manufacturing process
T Vasconcelos, S Marques, J das Neves, B Sarmento
Advanced drug delivery reviews 100, 85-101, 2016
1862016
Development of a rapid dissolving ibuprofen solid dispersion
T Vasconcelos, P Costa
Pharm. Res 16, 676-681, 2007
312007
Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems
T Vasconcelos, S Marques, B Sarmento
European Journal of Pharmaceutics and Biopharmaceutics 123, 1-8, 2018
212018
Pharmaceutical composition for poorly soluble drugs
TC De Vasconcelos
US Patent App. 12/920,025, 2011
212011
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 9,132,094, 2015
19*2015
The biopharmaceutical classification system of excipients
Vasconcelos, Teofilo, S Marques, bruno Sarmento
Therapeutic delivery 8 (2), 65-78, 2017
162017
Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine Acetate
C Fontes-Ribeiro, T Macedo, T Nunes, C Neta, T Vasconcelos, ...
Drugs in R & D 9 (6), 447-454, 2008
162008
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
TC de Vasconcelos, RJ dos Santos Lima, PM da Costa Barrocas, ...
US Patent App. 12/750,957, 2010
122010
Gellan gum/pectin beads are safe and efficient for the targeted colonic delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, SP Campana-Filho, A Almeida, ...
Polymers 10 (1), 50, 2018
112018
Bioequivalence of final tablet formulation and research tablet formulation of eslicarbazepine acetate in healthy volunteers
R Lima, T Vasconcelos, R Cerdeira, M Lefebvre, E Sicard
J Bioequiv Availab 1 (3), 93-98, 2009
112009
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
8*2013
Solubility enhancement as strategies to improve oral bioavailability of poorly water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12, 1281-1302, 2007
82007
Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
T Vasconcelos, F Araújo, C Lopes, A Loureiro, J das Neves, S Marques, ...
European Journal of Pharmaceutical Sciences 137, 105011, 2019
62019
Polymer-based delivery systems for oral delivery of peptides and proteins
B Sarmento, D Ferreira, T Vasconcelos
Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic …, 2009
62009
Development of a Resveratrol Solid Dispersion with Soluplus®
T Vasconcelos, S Marques, B Sarmento
42nd Annual Meeting & Exposition of the Controlled Release Society, 2015
22015
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, A Almeida, T Vasconcelos, ...
Drug Development and Industrial Pharmacy 46 (2), 236-245, 2020
12020
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20